Rapid acceleration of diagnostics ( radx) program: tech project #2322 microgem (microlab)
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92020C00015
- Awardee
-
Microgem US Inc. UEI M2K4MLEKGDS6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $50,734,479
Award facts
- Opportunity
-
- RADx Tech Accurate, Sensitive and Affordable POC Device Pre-Solicitation · Posted Aug 13, 2021
- Rapid Acceleration of Diagnostics (RADx): Tech Project No. 2322 Award Notice · Posted Jan 27, 2021
- Contract value 100% obligated
- $50,734,479.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Charlottesville, VA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $9,806,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Definitize Letter Contract | $24,369,230 | |
| Original award | $16,559,249 |
About this award
The National Institutes of Health awarded a $50.7 million firm fixed price modification to MicroGEM US Inc. under the RADX Tech Program. The modification extends an existing contract to maintain MicroGEM's production of 160,000 saliva-based, high-performing RT-PCR point-of-care cartridges and 1,000 portable devices per day for COVID-19 testing. The 25-minute tests and devices are non-invasive and portable. Funding comes from the Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute to support increased testing demands due to the Delta variant under the Rapid Acceleration of Diagnostics Program. There is no set-aside designation. MicroGEM US Inc. is the prime contractor providing the saliva tests and devices from their Charlottesville, Virginia location over a two year period ending August 2022.
Quick answers
Who was awarded contract 75N92020C00015?
75N92020C00015 was awarded to Microgem US Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 28, 2020.
How much is contract 75N92020C00015 worth?
The government has obligated $50,734,479 on 75N92020C00015.
Was contract 75N92020C00015 competed?
The extent of competition for 75N92020C00015 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award